Fig. 1
From: Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series
Clinical characteristics (A), hematologic (B) and rheumatologic (C) laboratory evaluation, and therapies and outcomes (D) observed in patients with NC-aPL. Interpretation key is shown to the right. Ranges of values for complement C3, C4, CH50, and total IgG for each individual patient are shown in cells in (C). Abbreviations: INR: international normalized ratio, PTT: partial thromboplastin time, ANA: antinuclear antibodies, ENA: antibodies to extractable nuclear antigens, dsDNA: anti-double stranded DNA